Jennison Associates’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.8M | Sell |
696,383
-80,310
| -10% | -$2.51M | 0.01% | 325 |
|
|
2025
Q1 | $26.1M | Sell |
776,693
-24,860
| -3% | -$834K | 0.02% | 302 |
|
|
2024
Q4 | $31.4M | Buy |
801,553
+224,892
| +39% | +$8.82M | 0.02% | 291 |
|
|
2024
Q3 | $22.7M | Buy |
576,661
+6,389
| +1% | +$252K | 0.01% | 328 |
|
|
2024
Q2 | $22.2M | Buy |
570,272
+6,320
| +1% | +$246K | 0.01% | 317 |
|
|
2024
Q1 | $24.3M | Sell |
563,952
-2,444
| -0.4% | -$105K | 0.02% | 324 |
|
|
2023
Q4 | $26.1M | Buy |
566,396
+352,573
| +165% | +$16.2M | 0.02% | 299 |
|
|
2023
Q3 | $7.3M | Buy |
213,823
+25,432
| +13% | +$869K | 0.01% | 391 |
|
|
2023
Q2 | $7.25M | Buy |
+188,391
| New | +$7.25M | 0.01% | 400 |
|